rs748235
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000188.3(HK1):c.1443G>A(p.Lys481Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.789 in 1,613,684 control chromosomes in the GnomAD database, including 505,029 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.80 ( 49185 hom., cov: 32)
Exomes 𝑓: 0.79 ( 455844 hom. )
Consequence
HK1
NM_000188.3 synonymous
NM_000188.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.894
Genes affected
HK1 (HGNC:4922): (hexokinase 1) Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. This gene encodes a ubiquitous form of hexokinase which localizes to the outer membrane of mitochondria. Mutations in this gene have been associated with hemolytic anemia due to hexokinase deficiency. Alternative splicing of this gene results in several transcript variants which encode different isoforms, some of which are tissue-specific. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 10-69382664-G-A is Benign according to our data. Variant chr10-69382664-G-A is described in ClinVar as [Benign]. Clinvar id is 255483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-69382664-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.894 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.872 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HK1 | NM_001358263.1 | c.1455G>A | p.Lys485Lys | synonymous_variant | Exon 13 of 21 | ENST00000643399.2 | NP_001345192.1 | |
HK1 | NM_000188.3 | c.1443G>A | p.Lys481Lys | synonymous_variant | Exon 10 of 18 | ENST00000359426.7 | NP_000179.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HK1 | ENST00000643399.2 | c.1455G>A | p.Lys485Lys | synonymous_variant | Exon 13 of 21 | NM_001358263.1 | ENSP00000494664.1 | |||
HK1 | ENST00000359426.7 | c.1443G>A | p.Lys481Lys | synonymous_variant | Exon 10 of 18 | 1 | NM_000188.3 | ENSP00000352398.6 |
Frequencies
GnomAD3 genomes AF: 0.800 AC: 121654AN: 152012Hom.: 49144 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
121654
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.772 AC: 193253AN: 250250 AF XY: 0.784 show subpopulations
GnomAD2 exomes
AF:
AC:
193253
AN:
250250
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.787 AC: 1150645AN: 1461554Hom.: 455844 Cov.: 67 AF XY: 0.791 AC XY: 575295AN XY: 727088 show subpopulations
GnomAD4 exome
AF:
AC:
1150645
AN:
1461554
Hom.:
Cov.:
67
AF XY:
AC XY:
575295
AN XY:
727088
Gnomad4 AFR exome
AF:
AC:
29826
AN:
33480
Gnomad4 AMR exome
AF:
AC:
25964
AN:
44620
Gnomad4 ASJ exome
AF:
AC:
21757
AN:
26092
Gnomad4 EAS exome
AF:
AC:
23056
AN:
39694
Gnomad4 SAS exome
AF:
AC:
76721
AN:
86214
Gnomad4 FIN exome
AF:
AC:
42474
AN:
53408
Gnomad4 NFE exome
AF:
AC:
877987
AN:
1111894
Gnomad4 Remaining exome
AF:
AC:
48081
AN:
60384
Heterozygous variant carriers
0
15257
30515
45772
61030
76287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20666
41332
61998
82664
103330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.800 AC: 121755AN: 152130Hom.: 49185 Cov.: 32 AF XY: 0.798 AC XY: 59392AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
121755
AN:
152130
Hom.:
Cov.:
32
AF XY:
AC XY:
59392
AN XY:
74382
Gnomad4 AFR
AF:
AC:
0.879529
AN:
0.879529
Gnomad4 AMR
AF:
AC:
0.662503
AN:
0.662503
Gnomad4 ASJ
AF:
AC:
0.834389
AN:
0.834389
Gnomad4 EAS
AF:
AC:
0.646887
AN:
0.646887
Gnomad4 SAS
AF:
AC:
0.88428
AN:
0.88428
Gnomad4 FIN
AF:
AC:
0.805115
AN:
0.805115
Gnomad4 NFE
AF:
AC:
0.785048
AN:
0.785048
Gnomad4 OTH
AF:
AC:
0.79072
AN:
0.79072
Heterozygous variant carriers
0
1232
2465
3697
4930
6162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2712
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Retinitis pigmentosa 79 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hemolytic anemia due to hexokinase deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neurodevelopmental disorder with visual defects and brain anomalies Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Charcot-Marie-Tooth disease type 4G Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at